Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €35.24 EUR
Change Today +0.154 / 0.44%
Volume 0.0
3M4 On Other Exchanges
Symbol
Exchange
Berlin
As of 9:34 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

masimo corp (3M4) Snapshot

Open
€34.84
Previous Close
€35.09
Day High
€35.24
Day Low
€34.84
52 Week High
08/5/15 - €40.11
52 Week Low
09/24/14 - €15.94
Market Cap
1.8B
Average Volume 10 Days
26.0
EPS TTM
--
Shares Outstanding
51.0M
EX-Date
11/23/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MASIMO CORP (3M4)

masimo corp (3M4) Related Businessweek News

No Related Businessweek News Found

masimo corp (3M4) Details

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. It offers Masimo Signal Extraction Technology (SET) with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. The company also provides Masimo rainbow SET Platform, which includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor multiple blood-based measurements, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from pleth; noninvasively monitor hemoglobin, carboxyhemoglobin, and methemoglobin; monitor arterial oxygen saturation; and calculates oxygen content and oxygen reserve index. In addition, it offers SedLine brain function monitoring technology that measures the brain’s electrical activity by detecting EEG signals; capnography and gas monitoring products, such as external plug-in-and-measure capnography and gas analyzers, integrated modules, and handheld capnograph and capnometer devices; O3 regional oximetry for tissue oxygen saturation measurement; SafetyNet, a patient surveillance, remote monitoring, and clinician notification solution; and Halo Index, an indicator that facilitates trending and assessment of physiological measurements. Further, the company offers remote alarm/monitoring solutions, software, and connectivity solutions. The company’s patient monitoring technologies incorporate a monitor or circuit board and sensors, including proprietary single-patient use, reusable and rainbow ReSposable sensors, and patient cables. Masimo Corporation provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. The company was founded in 1989 and is headquartered in Irvine, California.

1,200 Employees
Last Reported Date: 02/17/15
Founded in 1989

masimo corp (3M4) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $830.8K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $346.1K
Chief Operating Officer
Total Annual Compensation: $307.8K
President of Worldwide Oem Business & Blood M...
Total Annual Compensation: $347.4K
President of Worldwide Sales, Professional Se...
Total Annual Compensation: $332.4K
Compensation as of Fiscal Year 2014.

masimo corp (3M4) Key Developments

Masimo Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended July 4, 2015; Provides Earnings Guidance for the Year Ending January 2, 2016

Masimo Corporation reported unaudited consolidated earnings results for the second quarter and six months ended July 4, 2015. For the quarter, the company reported total revenue of $155,726,000 against $140,923,000 a year ago. Operating income was $27,841,000 against $18,405,000 a year ago. Income before provision for income taxes was $26,716,000 against $18,728,000 a year ago. Net income attributable to company stockholders was $19,351,000 or $0.36 per share diluted against $13,802,000 or $0.24 per share diluted a year ago. Non-GAAP net income attributable to company stockholders was $23,057,000 or $0.43 per share diluted against $14,102,000 or $0.25 per share diluted a year ago. For the six months, the company reported total revenues of $310,263,000 against $280,737,000 a year ago. Operating income was $55,218,000 against $48,598,000 a year ago. Income before provision for income taxes was $54,246,000 against $49,121,000 a year ago. Net income attributable to company stockholders was $39,874,000 or $0.74 per share diluted against $36,434,000 or $0.63 per share diluted a year ago. Net cash provided by operating activities was $28,276,000 against $38,825,000 a year ago. Purchase of property and equipment was $24,665,000 against $62,093,000 a year ago. Non-GAAP net income attributable to company stockholders was $45,249,000 or $0.84 per share diluted against $31,500,000 or $0.55 per share diluted a year ago. For the year ending January 2, 2016, the company expects GAAP EPS guidance of $1.43 per share. Total non-GAAP EPS guidance of $1.61 per share.

Masimo Corporation Provides Earnings Guidance for the Second Quarter of 2015

Masimo Corporation provided earnings guidance for the second quarter of 2015. For the quarter, the company expects that its product revenue will range from $147.0 million to $148.0 million, and that its royalty revenue for the quarter will be approximately $8.0 million. As a result, the company now expects its total second quarter revenues to range from $155.0 million to $156.0 million. The company also estimates that its second quarter of 2015 fully-diluted GAAP earnings per share will be between $0.35 and $0.36.

Masimo Corporation to Report Q2, 2015 Results on Aug 04, 2015

Masimo Corporation announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Aug 04, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3M4:GR €35.24 EUR +0.154

3M4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $51.23 USD -0.15
Cyberonics Inc $64.15 USD +0.62
ICU Medical Inc $111.30 USD +1.30
Integra LifeSciences Holdings Corp $60.24 USD +1.89
NuVasive Inc $52.15 USD +0.14
View Industry Companies
 

Industry Analysis

3M4

Industry Average

Valuation 3M4 Industry Range
Price/Earnings 28.1x
Price/Sales 3.3x
Price/Book 7.1x
Price/Cash Flow 26.6x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORP, please visit www.masimo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.